文献速递消化内镜消化道肿瘤与早癌

比较钳夹活检取样与宽区域经上皮取样刷在上消化道内镜检查中检测肠化生和异型增生的多中心随机对照试验

Multicenter randomized controlled trial comparing forceps biopsy sampling with wide-area transepithelial sampling brush for detecting intestinal metaplasia and dysplasia during routine upper endoscopy.
PubMed 文献 · Gastrointest Endosc · 2021-12-10

在美国9个中心将1002例因前肠症状或巴雷特食管监测行上消化道内镜的患者随机分为钳夹活检组(505例)和宽区域经上皮取样刷组(497例),两组总体肠化生检出率相似(19.6% vs 22.7%,P=.2),但在无肠化生病史且内镜下见柱状上皮化食管者中宽区域经上皮取样刷检出肠化生显著更多(32.4% vs 15.2%,P=.004)。

要点

  • 钳夹活检与宽区域经上皮取样刷总体肠化生检出率相似(19.6% vs 22.7%,P=.2)。
  • 无肠化生病史且内镜见柱状上皮化食管者,宽区域经上皮取样刷检出肠化生更多(32.4% vs 15.2%,P=.004)。
  • 已知巴雷特食管患者中两种方法检出肠化生和异型增生频率相似。

核心结论

  • 总体上钳夹活检与宽区域经上皮取样刷检测肠化生和异型增生的频率相似,宽区域经上皮取样刷在无巴雷特食管病史且内镜见柱状上皮化食管的患者中检出肠化生的可能性是钳夹活检的两倍。
  • 作者认为宽区域经上皮取样刷可替代钳夹活检,在检测肠化生和异型增生方面疗效相似或更优。

研究设计与样本

  • 多中心随机对照试验,在美国9个中心纳入因前肠症状或巴雷特食管监测行上消化道内镜的患者,随机分为钳夹活检组(505例)和宽区域经上皮取样刷组(497例),共1002例。

主要发现

  • 总体肠化生检出率为21%,钳夹活检组为19.6%,宽区域经上皮取样刷组为22.7%(P=.2)。
  • 低级别异型增生见于8例患者,无患者发现高级别异型增生,两种方法检出异型增生无差异。
  • 无肠化生病史且内镜见柱状上皮化食管的患者中,宽区域经上皮取样刷检出肠化生32.4%,钳夹活检检出15.2%(P=.004)。
  • 184例已知巴雷特食管患者中,钳夹活检与宽区域经上皮取样刷检出肠化生频率相似(38.5% vs 41.9%,P=.6),短段和长段巴雷特食管均无差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Intestinal metaplasia (IM) in the esophagus is a potentially premalignant mucosal change. The aim of this study was to compare the frequency of IM detection during upper endoscopy by forceps biopsy sampling (FB) versus wide-area transepithelial sampling (WATS) brush. METHODS: Patients presenting for upper endoscopy for foregut symptoms or surveillance of Barrett's esophagus (BE) at 9 centers in the United States were randomized to either FB or WATS. RESULTS: Of 1002 patients, FB was done in 505 and WATS in 497. The overall frequency of finding IM was 21% and was similar with FB (19.6%) and WATS (22.7%, P = .2). Low-grade dysplasia was found in 8 patients. No patient had high-grade dysplasia. There was no difference in detection of dysplasia between FB and WATS. In patients with no history of IM, WATS found significantly more IM compared with FB when a columnar-lined esophagus (CLE) was present (32.4% with WATS vs 15.2% with FB, P = .004). In 184 patients with known BE, FB and WATS found IM with similar frequency (38.5% FB vs 41.9% WATS, P = .6) with no difference in short- or long-segment BE. CONCLUSIONS: Overall, FB and WATS detected a similar frequency of IM and dysplasia. WATS was twice as likely as FB to find IM in patients without a history of BE who had CLE on endoscopy. In patients with known BE, WATS and FB showed IM and dysplasia with similar frequency. These findings suggest that WATS can be used instead of FB with similar or improved efficacy at detecting IM and dysplasia. (Clinical trial registration number: NCT03859557.).

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. DeMeester S, Smith C, Severson P, et al. Multicenter randomized controlled trial comparing forceps biopsy sampling with wide-area transepithelial sampling brush for detecting intestinal metaplasia and dysplasia during routine upper endoscopy. Gastrointest Endosc. 2021. PMID: 34902373. doi:10.1016/j.gie.2021.11.044

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。